Litcius/Paper detail

Effect of Rivaroxaban or Apixaban in Atrial Fibrillation Patients with Stage 4–5 Chronic Kidney Disease or on Dialysis

Chen Chen, Yalin Cao, Ying Zheng, Yugang Dong, Jianyong Ma, Wengen Zhu, Chen Liu

2021Cardiovascular Drugs and Therapy29 citationsDOI

Topics & Concepts

ApixabanRivaroxabanMedicineWarfarinAtrial fibrillationInternal medicineStroke (engine)Kidney diseaseHazard ratioDialysisDabigatranCardiologyConfidence intervalEngineeringMechanical engineeringAtrial Fibrillation Management and OutcomesAcute Kidney Injury ResearchPotassium and Related Disorders
Effect of Rivaroxaban or Apixaban in Atrial Fibrillation Patients with Stage 4–5 Chronic Kidney Disease or on Dialysis | Litcius